Karin C. Berger

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Epidemiology, Health Care Resource Utilization, and Costs of Hemophilia A and B by Treatment Regimen: A Retrospective Analysis of German Claims Data from 2016 to 2021.

Epidemiology, Health Care Resource Utilization, and Costs of Hemophilia A and B by Treatment Regimen: A Retrospective Analysis of German Claims Data from 2016 to 2021.

Journal: Hamostaseologie
Published: July 14, 2025

Triangulating data to define patient pathways, diagnostic and treatment patterns, and outcomes in cancer patients with deep vein thrombosis in Germany: a mixed-methods real-world data study.

Triangulating data to define patient pathways, diagnostic and treatment patterns, and outcomes in cancer patients with deep vein thrombosis in Germany: a mixed-methods real-world data study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 30, 2025

Follicular lymphoma or diffuse large B-cell lymphoma: a population based analysis of epidemiological and health economic aspects in Germany.

Follicular lymphoma or diffuse large B-cell lymphoma: a population based analysis of epidemiological and health economic aspects in Germany.

Journal: Annals of hematology
Published: July 30, 2024

Can German Health Insurance Claims Data Fill Information Gaps in Rare Chronic Diseases: Use Case of Haemophilia A.

Can German Health Insurance Claims Data Fill Information Gaps in Rare Chronic Diseases: Use Case of Haemophilia A.

Journal: Hamostaseologie
Published: July 01, 2024

Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity.

Early mortality in atezolizumab/bevacizumab for HCC is associated with impaired liver function and alterations of systemic immunity.

Journal: JHEP reports : innovation in hepatology
Published: May 12, 2024

Challenges associated with access to recently developed hemophilia treatments in routine care: perspectives of healthcare professionals.

Challenges associated with access to recently developed hemophilia treatments in routine care: perspectives of healthcare professionals.

Journal: Haematologica
Published: April 15, 2024

Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study.

Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: December 10, 2023

Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany.

Budget Impact Analysis of CAR T-cell Therapy for Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma in Germany.

Journal: HemaSphere
Published: December 06, 2021

Are all licensed haemostatic agents for haemophilia therapy accessible to patients?

Are all licensed haemostatic agents for haemophilia therapy accessible to patients?

Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: October 05, 2021

Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective.

Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective.

Journal: Clinical lymphoma, myeloma & leukemia
Published: October 04, 2021

Transparency on Platelet Transfusion in Routine Cancer Care: The Key for Optimal Blood Usage?

Transparency on Platelet Transfusion in Routine Cancer Care: The Key for Optimal Blood Usage?

Journal: Oncology research and treatment
Published: September 28, 2021

Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015-2017.

Usability of German hospital administrative claims data for healthcare research: General assessment and use case of multiple myeloma in Munich university hospital in 2015-2017.

Journal: PloS one
Published: August 19, 2021
Showing 1-12 of 33

Last Updated: 09/26/2026